Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis

Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis

Objective: to evaluate the efficacy and safety of the biosimilar etanercept (ETC, Altebrel) in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) in clinical practice.Material and methods. The study included 20 patients with a confirmed diagnosis of RA and 8 with SpA: 5 with axial S...

Full description

Saved in:
Bibliographic Details
Main Authors: B. G. Issayeva, D. S. Dilmanova, A. S. Amanzholova, S. M. Issayeva, A. B. Kanapina, A. E. Turtaeva, G. Sh. Trimova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-10-01
Series:Современная ревматология
Subjects:
rheumatoid arthritis
spondyloarthritis
etanercept
etanercept bioanalogue altebrel
Online Access:https://mrj.ima-press.net/mrj/article/view/1641
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://mrj.ima-press.net/mrj/article/view/1641

Similar Items